Cargando…

VEGFR-1 blockade disrupts peri-implantation decidual angiogenesis and macrophage recruitment

BACKGROUND: Angiogenesis and macrophage recruitment to the uterus are key features of uterine decidualization; the progesterone-mediated uterine changes that allow for embryo implantation and initiation of pregnancy. In the current study, we characterized the expression of vascular endothelial growt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douglas, Nataki C, Zimmermann, Ralf C, Tan, Qian Kun, Sullivan-Pyke, Chantae S, Sauer, Mark V, Kitajewski, Jan K, Shawber, Carrie J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122670/ https://www.ncbi.nlm.nih.gov/pubmed/25101167 http://dx.doi.org/10.1186/2045-824X-6-16

Ejemplares similares

Vascular Notch proteins and Notch signaling in the peri-implantation mouse uterus
por: Shawber, Carrie J., et al.
Publicado: (2015)

Endothelial Jagged1 Antagonizes Dll4/Notch Signaling in Decidual Angiogenesis during Early Mouse Pregnancy
por: Marchetto, Nicole M., et al.
Publicado: (2020)

Dominant-negative inhibition of canonical Notch signaling in trophoblast cells does not disrupt placenta formation
por: Shawber, Carrie J., et al.
Publicado: (2019)

Notch regulates the angiogenic response via induction of VEGFR-1
por: Funahashi, Yasuhiro, et al.
Publicado: (2010)

Intraovarian regulation of gonadotropin-dependent folliculogenesis depends on notch receptor signaling pathways not involving Delta-like ligand 4 (Dll4)
por: Jovanovic, Vuk P, et al.
Publicado: (2013)

Lymphatics in health and disease: a new thematic series in vascular cell
por: Kitajewski, Jan, et al.
Publicado: (2013)

Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye
por: Huang, Hu, et al.
Publicado: (2011)

Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Notch and VEGF pathways play distinct but complementary roles in tumor angiogenesis
por: Hernandez, Sonia L, et al.
Publicado: (2013)

Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response
por: Zafarnia, Sara, et al.
Publicado: (2017)

Broussonin A– and B–mediated inhibition of angiogenesis by blockade of VEGFR‐2 signalling pathways and integrin β1 expression
por: Kim, Jae Hyeon, et al.
Publicado: (2022)

VEGFR1 signaling in retinal angiogenesis and microinflammation
por: Uemura, Akiyoshi, et al.
Publicado: (2021)

Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin
por: Rusnati, Marco, et al.
Publicado: (2021)

Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity
por: Funahashi, Yasuhiro, et al.
Publicado: (2011)

Abstract 11: CD133+ Endothelial Cells Isolated From Venous Malformation Recapitulates Clinical Phenotype in a Mouse Model
por: Grzesik, Peter, et al.
Publicado: (2017)

VEGF-dependent tumor angiogenesis requires the inverse and reciprocal regulation of VEGFR1 and VEGFR2
por: Zhang, Zhaocheng, et al.
Publicado: (2009)

VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
por: D'Haene, Nicky, et al.
Publicado: (2013)

Computational Modeling to Quantify the Contributions of VEGFR1, VEGFR2, and Lateral Inhibition in Sprouting Angiogenesis
por: Kühn, Clemens, et al.
Publicado: (2019)

Correction: Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin
por: Rusnati, Marco, et al.
Publicado: (2021)

Welcome to Journal of Angiogenesis Research
por: Slevin, Mark, et al.
Publicado: (2009)

Hepatic Notch Signaling Correlates With Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Valenti, Luca, et al.
Publicado: (2013)

Folate Deficiency Could Restrain Decidual Angiogenesis in Pregnant Mice
por: Li, Yanli, et al.
Publicado: (2015)

Probiotic Yeast Inhibits VEGFR Signaling and Angiogenesis in Intestinal Inflammation
por: Chen, Xinhua, et al.
Publicado: (2013)

Accelerated Coronary Angiogenesis by Vegfr1-Knockout Endocardial Cells
por: Zhang, Zheng, et al.
Publicado: (2013)

Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
por: Li, Jia, et al.
Publicado: (2019)

Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1–dependent manner
por: Pajvani, Utpal B., et al.
Publicado: (2011)

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers
por: Watanabe, Hiromi, et al.
Publicado: (2021)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

“Large eaters” meet blood vessels: a new thematic series on macrophages and angiogenesis
por: Kitajewski, Jan
Publicado: (2012)

VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis
por: Thurston, G, et al.
Publicado: (2008)

Exposure to cigarette smoke affects endometrial maturation including angiogenesis and decidualization
por: Kida, Naoko, et al.
Publicado: (2021)

SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis
por: Zhou, Huanjiao Jenny, et al.
Publicado: (2018)

Sialyllactose suppresses angiogenesis by inhibiting VEGFR-2 activation, and tumor progression
por: Chung, Tae-Wook, et al.
Publicado: (2017)

TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer
por: Zhong, Mengya, et al.
Publicado: (2020)

Tetraspanin18 regulates angiogenesis through VEGFR2 and Notch pathways
por: Li, Grace X., et al.
Publicado: (2021)

Evidence for G-quadruplex in the promoter of VEGFR-2 and its targeting to inhibit tumor angiogenesis
por: Salvati, E., et al.
Publicado: (2014)

Cinnamon extract inhibits angiogenesis in zebrafish and human endothelial cells by suppressing VEGFR1, VEGFR2, and PKC-mediated MAP kinase
por: Bansode, Rishipal R, et al.
Publicado: (2013)

Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
por: Jiang, Zongru, et al.
Publicado: (2020)

Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation
por: Munabi, Naikhoba C.O., et al.
Publicado: (2016)

A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
por: Azad, T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hh5a2244r2b8dru78k31jgo7uv